Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer

August 7 - 8

New York Marriott Marquis

Early-Phase Cancer Research Conference

Stop Cancer Logo Medium

Join us in New York for the annual "STOP Cancer" conference August 7th - 8th!

The Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer) is a multidisciplinary conference that brings together clinicians, scientists, researchers, and pharmaceutical industry experts to provide and gain insight into recent advances in cancer science and medicine.

The primary aim of the conference is to discuss recent advancements, challenges, and future directions in novel therapeutic agents and drug discovery, clinical trial design, molecular profiling, and precision oncology. STOP Cancer highlights the latest in early-phase research and the interpretation and application of precision medicine.

Advanced Registration

MD, DO, PhD

$ 490
00
  • Through July 7th

General Registration

MD, DO, PhD

$ 590
00
  • Through August 7th

Advanced Registration

Allied Health (NP, PA, RN, PharmD, Fellows, Residents, Retired)

$ 275
00
  • Through July 7th

General Registration

Allied Health (NP, PA, RN, PharmD, Fellows, Residents, Retired)

$ 375
00
  • Through August 7th

Conference Planning Committee

Hani Babiker, MD (Course Director)

Associate Professor of Medicine, Pancreaticobiliary, GI Oncology, Early Phase Therapeutics, and Consultant Mayo Clinic Jacksonville, FL

COURSE DIRECTOR

Mitesh Borad, MD

Professor of Medicine Mayo Clinic, College of Medicine and Science Phoenix, AZ

CO-DIRECTOR

Eytan M. Stein, MD

Chief, Leukemia Service Director, Program for Drug Development in Leukemia, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY

CHAIR

Elena Garralda, MD

Director - Research Unit for Molecular Therapy of Cancer, UITM – “CaixaResearch” (VHIO, Barcelona) Co-Director - Clinical Research Program (VHIO, Barcelona) Group Leader - Early Drug Development (VHIO, Barcelona) Medical Oncologist (HUVH, Barcelona) Director - Phase I Unit (NEXT Oncology, Barcelona) Barcelona, Spain

CHAIR

Anthony W. Tolcher, MD, FRCPC, FACP

Medical Oncologist, CEO and Founder of NEXT Oncology Texas Oncology-San Antonio Babcock Next Oncology San Antonio, TX

CHAIR

Vivek Subbiah, MD

Chief, Early-Phase Drug Development, Sarah Cannon Research Institute Nashville, TN

CHAIR

Presenting Faculty

TBA

TBA

TBA

TBA

TBA

TBA

TBA

TBA

TBA

TBA

Accommodations

New York Marriott Marquis

We want to ensure that your time at the 2026 STOP Cancer conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.

Overnight Accommodations:

Dates for discounted rates: August 6-8, 2026

Discounted Booking Deadline: July 4, 2026

Click here to book your room today!

Room rate: $359

Parking: Complimentary parking

Disclaimer

All reservations must be booked using the link above before the closing date listed. Overnight accommodation, parking, and resort fees will revert back to standard hotel pricing outside of the dates above. A set number of rooms have been blocked off for the discounted pricing. If all of those rooms have already been booked, discounted pricing may not be available for additional rooms or accommodations.